Gennex Laboratories share news, announcements and annual reports

BSE: 531739Pharmaceuticals & BiotechnologySmall Cap

Gennex Laboratories Ltd · Face value ₹1 · Listed May 1996

₹8.88₹0.29 (3.38%)

Share price at the BSE close on 27 Oct 2026. Previous close ₹8.59.

27 Oct: open ₹8.65, high ₹9.15, low ₹8.50

52-week range of traded prices to 27 Oct 2026

₹7.05Low, 30 Mar 2026₹17.25High, 28 Oct 2025

Market cap: ₹216 Cr2,248th largest listed
P/E: 11.74
P/B: 0.97
Dividend yield: Nonein the last 12 months
ROE: 9.0%
ROCE: 7.0%
Debt to equity: 0.15
Volume, BSE: 2,39,015

Gennex Laboratories has 553 announcements on record, routine notices left out; 3 in the 30 days to 28 Oct 2026, the latest on 1 Oct 2026.

Last results date

The last board meeting held for results; the company has not yet given notice of the next.Gennex Laboratories quarterly results

Aug14Fri

The board met on 14 Aug 2026 to consider quarterly results

Notice filed 29 Jul 2026

Gennex Laboratories annual reports, presentations and earnings calls

The company's own documents, latest first.Gennex Laboratories financials, year by year

Annual reports24

Annual report, year to Mar 20268 Sep 2026
Annual report, year to Mar 20258 Sep 2025
Annual report, year to Mar 20247 Sep 2024
Annual report, year to Mar 20239 Sep 2023
Annual report, year to Mar 20229 Sep 2022

19 earlier reports

Annual report, year to Mar 20218 Sep 2021
Annual report, year to Mar 20206 Sep 2020
Annual report, year to Mar 20196 Sep 2019
Annual report, year to Mar 201813 Aug 2018
Annual report, year to Mar 201717 Oct 2017
Annual report, year to Mar 201629 Oct 2016
Annual report, year to Mar 20157 Sep 2015
Annual report, year to Mar 20141 Nov 2014
Annual report, year to Mar 201320 Dec 2013
Annual report, year to Mar 2012Filing day not known
Annual report, year to Mar 201112 Dec 2011
Annual report, year to Mar 2010Filing day not known
Annual report, year to Mar 2008Filing day not known
Annual report, year to Mar 2007Filing day not known
Annual report, year to Mar 2006Filing day not known
Annual report, year to Mar 2005Filing day not known
Annual report, year to Mar 2002Filing day not known
Annual report, year to Mar 2000Filing day not known
Annual report, year to Mar 1999Filing day not known

Gennex Laboratories share news and announcements

Newest first. Page 1 of 12.

Oct 2026
- 1 Oct · Meeting
  In compliance to Regulation 44 of SEBI (LODR) Regulations, 2015, as amended from time to time, please find enclosed herewith voting results of the 41st eAGM of the Company held on September ....
Sep 2026
- 30 Sep · Management
  We would like to inform you that the Company has received approval of its members by Special ....
- 30 Sep · Meeting
  We are pleased to provide hereunder the proceedings of 41st eAGM of the Company held on Wednesday, September 30, 2026 through ....
- 8 Sep · Approval Of Additional Products From Drugs Control Administration, Government Of Andhra Pradesh For Our Subsidiary Company, Deccan Remedies Limited
  We are pleased to inform that our subsidiary company, M/s Deccan Remedies Limited has received approval from the Drugs Control Administration, Government of Andhra Pradesh granting License ....
- 4 Sep · Meeting
  Register of Members and Share Transfer Books of the Company will remain closed from September 23, 2026 to September 30, 2026 ....
- 4 Sep · Board meeting
  1. Draft Directors'/ Board Report for the Financial Year March 31, 2026; 2. The 41st Annual General Meeting of the Company to be held on Wednesday, September 30, 2026 at 12:30 P.M. through ....
Aug 2026
- 27 Aug · Board meeting
  Meeting on 4 Sep 2026: annual general meeting
- 27 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 04/09/2026 ,inter alia, to consider and approve 1. To decide regarding ....
- 14 Aug · Results
  In just concluded Meeting of Board of Directors, the Board approved and considered the following items: 1. Unaudited Standalone and Consolidated Financial Statement for the Quarter ended ....
- 14 Aug · Results
  In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ....
Jul 2026
- 29 Jul · Board meeting
  Meeting on 14 Aug 2026: quarterly results
- 29 Jul · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. The Unaudited Financial ....
Jun 2026
May 2026
- 30 May · Results
  In just concluded Meeting of Board of Directors, the Board approved and considered the following items: 1. Audited Standalone & Consolidated Financial Results for the Quarter and Year ....
- 30 May · Results
  In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Audited Standalone & Consolidated Financial results for the Quarter & Year Ended ....
- 26 May · Legal
  We refer to your email of 25th May, 2026 seeking clarification on your observation regarding significant movement noticed by the Exchange in the price of our company security at your exchange ....
- 25 May · Legal
  Exchange has sought clarification from Gennex Laboratories Ltd on May 25, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
- 19 May · Board meeting
  Meeting on 30 May 2026: audited results
- 19 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve With reference to the above ....
- 13 May · Meeting
  In compliance to Regulation 44 of SEBI (LODR) Regulations, 2015, as amended from time to time (Listing Regulations), please find enclosed herewith voting results of electronic Extraordinary ....
- 12 May · Meeting
  Pursuant to Reg.30 of SEBI (LODR) Regulations, 2015, we are pleased to provide hereunder the proceedings of Extraordinary General Meeting (EGM) of the Company held on Tuesday, May 12, 2026 ....
Apr 2026
- 20 Apr · Meeting
  Read with Schedule III and in furtherance to our intimation date April 16, 2026 and revised intimation dated April 17, 2026, we ....
- 17 Apr · Board meeting
  Revised outcome With reference to our earlier letter dated April 16, 2026, in this connection we would like to submit the revised outcome of the Board Meeting as follows: 1. Convening ....
- 16 Apr · Board meeting
  In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Convening of an Extraordinary General Meeting ('EGM') of the Company on Tuesday, ....
- 8 Apr · Board meeting
  Meeting on 16 Apr 2026
- 8 Apr · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 16/04/2026 ,inter alia, to consider and approve 1. To decide regarding ....
Feb 2026
- 14 Feb · Intimation Of Reconstitution Of Audit Committee, Stakeholders Relationship Committee And Nomination And Remuneration Committee Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulations, 2015
  We wish to inform you that the Board of Directors of the Company in their meeting held today i.e. February 14, 2026 reconstituted ....
- 14 Feb · Management
  We would like to inform you that based on recommendation of Nomination and Remuneration Committee ....
- 14 Feb · Management
  With reference to above captioned subject matter, this is to inform you that Ms. Shilpa Bung, Non-Executive Independent Women Director has tendered her resignation from the Board as Director ....
- 14 Feb · Quarter And Nine Months Ended December 31, 2025
  Unaudited (Standalone and Consolidated) Financial Results for 31.12.2025 along with Limited Review Report thereon.
- 14 Feb · Results
  1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Nine months ended December 31, 2025 2. Limited Review Report from the Statutory Auditor on Unaudited ....
- 5 Feb · Board meeting
  Meeting on 14 Feb 2026: quarterly results
- 5 Feb · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve 1. Consider and adopt the ....
Nov 2025
- 14 Nov · Results
  In just concluded meeting of Board of Directors , the Board approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the quarter ....
- 14 Nov · Results
  In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ....
- 4 Nov · Board meeting
  Meeting on 14 Nov 2025: quarterly results
- 4 Nov · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve 1. The Unaudited Financial ....
Oct 2025
- 1 Oct · Meeting
  In compliance to Regulation 44 of SEBI (LODR) Regulations, 2015, as amended from time to time (Listing Regulations), please find enclosed herewith voting results of the 40th electroic Annual ....
Sep 2025
Aug 2025
- 26 Aug · Board meeting
  Meeting on 4 Sep 2025: annual general meeting
- 26 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 04/09/2025 ,inter alia, to consider and approve With reference to the above ....
- 14 Aug · Results
  In just concluded Meeting of Board of Directors, the Board approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ....
- 14 Aug · Results
  In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ....
Jul 2025
- 28 Jul · Approval Of Products From Drugs Control Administration, Government Of Andhra Pradesh For Our Subsidiary Company, Deccan Remedies Limited
  We are pleased to inform that our subsidiary Company, M/s Deccan Remedies Limited, has received approval from Drug Control Administration, Government of Andhra Pradesh granting License ....
- 28 Jul · Board meeting
  Meeting on 14 Aug 2025: quarterly results

How the price met the news

The first session after each announcement, beside the market.

That dayAgainst the Nifty 500Market median on that newsFive sessionsFive sessions against the Nifty 500Volume, times usual

1 Oct 2026Board or managers changeddown 1.51%−0.5 pts vs Nifty 500market median 0.0% · five sessions −1.8% (+0.3 pts vs Nifty 500) · volume 0.8× usual · The announcement
11 Jun 2026Pledgedown 2.90%−2.4 pts vs Nifty 500market median −0.2% · five sessions +1.0% (−3.0 pts vs Nifty 500) · volume 0.3× usual · The announcement
16 Feb 2026Board or managers changeddown 2.61%−3.3 pts vs Nifty 500market median 0.0% · five sessions −4.6% (−5.0 pts vs Nifty 500) · volume 1.2× usual · The announcement
2 Jun 2025Board or managers changeddown 4.89%−5.0 pts vs Nifty 500market median 0.0% · five sessions −4.9% (−6.5 pts vs Nifty 500) · volume 2.7× usual · The announcement
24 Mar 2025Pledgedown 1.13%−2.4 pts vs Nifty 500market median −0.2% · five sessions −15.3% (−15.6 pts vs Nifty 500) · volume 1.5× usual · The announcement
21 Mar 2025Pledgedown 3.72%−4.7 pts vs Nifty 500market median −0.2% · five sessions −18.7% (−20.3 pts vs Nifty 500) · volume 0.9× usual · The announcement
17 Feb 2025Board or managers changeddown 0.87%−1.0 pts vs Nifty 500market median 0.0% · five sessions +11.6% (+11.3 pts vs Nifty 500) · volume 1.6× usual · The announcement
11 Feb 2025Board or managers changeddown 9.11%−7.1 pts vs Nifty 500market median 0.0% · five sessions −9.3% (−6.0 pts vs Nifty 500) · volume 4.1× usual · The announcement
18 Nov 2024Board or managers changeddown 0.42%−0.1 pts vs Nifty 500market median 0.0% · five sessions +2.0% (−0.6 pts vs Nifty 500) · volume 0.4× usual · The announcement
7 Oct 2024Board or managers changedup 4.97%+6.5 pts vs Nifty 500market median 0.0% · five sessions −0.4% (−0.7 pts vs Nifty 500) · volume 4.9× usual · The announcement

15 earlier announcements

1 Oct 2024Board or managers changeddown 4.98%−5.1 pts vs Nifty 500market median 0.0% · five sessions +2.7% (+5.7 pts vs Nifty 500) · volume 2.9× usual · The announcement
10 Sep 2024Board or managers changedup 4.93%+4.3 pts vs Nifty 500market median 0.0% · five sessions +25.1% (+23.2 pts vs Nifty 500) · volume 2.9× usual · The announcement
16 Aug 2024Board or managers changedup 9.94%+8.3 pts vs Nifty 500market median 0.0% · five sessions +18.0% (+14.6 pts vs Nifty 500) · volume 7.9× usual · The announcement
5 Feb 2024Board or managers changedup 1.96%+2.3 pts vs Nifty 500market median 0.0% · five sessions +2.0% (+1.7 pts vs Nifty 500) · volume 0.6× usual · The announcement
2 Feb 2024Board or managers changedup 1.95%+1.3 pts vs Nifty 500market median 0.0% · five sessions +6.1% (+5.0 pts vs Nifty 500) · volume 0.5× usual · The announcement
18 Oct 2023Pledgedown 2.66%−2.0 pts vs Nifty 500market median −0.2% · five sessions −11.1% (−7.0 pts vs Nifty 500) · volume 0.3× usual · The announcement
8 Feb 2023Board or managers changeddown 2.57%−3.4 pts vs Nifty 500market median 0.0% · five sessions +0.7% (+0.3 pts vs Nifty 500) · volume 1.7× usual · The announcement
23 Nov 2022Pledge0.00%−0.2 pts vs Nifty 500market median −0.2% · five sessions −0.5% (−2.4 pts vs Nifty 500) · volume 0.9× usual · The announcement
21 Nov 2022Pledgedown 1.77%−1.1 pts vs Nifty 500market median −0.2% · five sessions −2.7% (−3.9 pts vs Nifty 500) · volume 3.9× usual · The announcement
16 Sep 2022Pledgeup 2.19%+4.3 pts vs Nifty 500market median −0.2% · five sessions −1.8% (−0.2 pts vs Nifty 500) · volume 0.6× usual · The announcement
11 Aug 2022Pledgedown 0.60%−1.3 pts vs Nifty 500market median −0.2% · five sessions −2.1% (−4.9 pts vs Nifty 500) · volume 0.5× usual · The announcement
27 Jul 2022Pledgedown 0.45%−1.3 pts vs Nifty 500market median −0.2% · five sessions −2.6% (−7.8 pts vs Nifty 500) · volume 1.3× usual · The announcement
26 Jul 2022Pledgedown 2.78%−1.8 pts vs Nifty 500market median −0.2% · five sessions −4.8% (−8.8 pts vs Nifty 500) · volume 1.2× usual · The announcement
30 Apr 2021Board or managers changeddown 0.91%+0.4 pts vs Nifty 500market median 0.0% · five sessions −12.7% (−12.5 pts vs Nifty 500) · volume 1.4× usual · The announcement
13 Nov 2020Board or managers changedup 0.28%−0.2 pts vs Nifty 500market median 0.0% · five sessions +3.3% (+2.0 pts vs Nifty 500) · volume 0.8× usual · The announcement

Sharp moves

The latest 30. 19 of the 30 shown had no filing that day or the next.

MoveAgainst the Nifty 500Times its usual moveVolume, times usualFilings

17 Aug 20263 filingsup 10.91%+11.0 pts vs Nifty 5003.2× its usual move · volume 9.2× usual
14 Aug 20263 filingsup 13.30%+13.6 pts vs Nifty 5004.5× its usual move · volume 13.0× usual
22 May 2026No filing that day or the nextup 11.14%+10.9 pts vs Nifty 5002.3× its usual move · volume 5.7× usual
19 May 20263 filingsup 19.93%+19.7 pts vs Nifty 5004.8× its usual move · volume 12.2× usual
2 Apr 2026No filing that day or the nextup 10.06%+10.0 pts vs Nifty 5002.6× its usual move · volume 1.6× usual
1 Apr 2026No filing that day or the nextup 19.92%+17.9 pts vs Nifty 5007.0× its usual move · volume 1.3× usual
30 Mar 2026No filing that day or the nextdown 10.99%−8.6 pts vs Nifty 5004.4× its usual move · volume 2.7× usual
23 Mar 2026No filing that day or the nextdown 9.89%−6.8 pts vs Nifty 5003.7× its usual move · volume 2.7× usual
30 Dec 2025No filing that day or the nextup 10.76%+10.8 pts vs Nifty 5003.1× its usual move · volume 8.8× usual
27 Oct 2025No filing that day or the nextup 11.91%+11.3 pts vs Nifty 5004.3× its usual move · volume 5.9× usual

20 earlier moves

14 Oct 20251 filingup 8.82%+9.3 pts vs Nifty 5003.5× its usual move · volume 5.8× usual
10 Jul 2025No filing that day or the nextup 9.31%+9.7 pts vs Nifty 5004.0× its usual move · volume 8.9× usual
19 Feb 2025No filing that day or the nextup 9.98%+9.4 pts vs Nifty 5003.3× its usual move · volume 2.6× usual
11 Feb 20252 filingsdown 9.11%−7.1 pts vs Nifty 5003.7× its usual move · volume 4.1× usual
16 Aug 20245 filingsup 9.94%+8.3 pts vs Nifty 5003.7× its usual move · volume 7.9× usual
15 May 2024No filing that day or the nextup 17.01%+16.7 pts vs Nifty 5003.8× its usual move · volume 22.4× usual
11 Mar 2024No filing that day or the nextdown 9.96%−9.2 pts vs Nifty 5003.0× its usual move · volume 1.0× usual
9 Oct 20231 filingup 19.15%+20.1 pts vs Nifty 5004.5× its usual move · volume 8.1× usual
6 Oct 20231 filingup 16.01%+15.4 pts vs Nifty 5004.2× its usual move · volume 9.2× usual
1 Aug 2023No filing that day or the nextup 19.88%+19.9 pts vs Nifty 5008.6× its usual move · volume 27.3× usual
26 Jul 2023No filing that day or the nextup 10.75%+10.3 pts vs Nifty 5006.2× its usual move · volume 7.1× usual
11 Jul 20231 filingup 5.58%+5.0 pts vs Nifty 5003.4× its usual move · volume 2.8× usual
26 Dec 2022No filing that day or the nextdown 11.26%−12.9 pts vs Nifty 5003.8× its usual move · volume 5.6× usual
23 Dec 2022No filing that day or the nextup 16.98%+19.5 pts vs Nifty 5008.4× its usual move · volume 10.1× usual
22 Dec 2022No filing that day or the nextup 11.60%+12.2 pts vs Nifty 5008.2× its usual move · volume 5.6× usual
8 Dec 2022No filing that day or the nextup 4.81%+4.5 pts vs Nifty 5003.7× its usual move · volume 1.4× usual
15 Jun 20221 filingup 15.05%+15.1 pts vs Nifty 5005.4× its usual move · volume 1.7× usual
29 Dec 2021No filing that day or the nextup 9.91%+9.9 pts vs Nifty 5003.1× its usual move · volume 4.9× usual
28 Dec 20212 filingsup 9.90%+8.9 pts vs Nifty 5003.4× its usual move · volume 2.0× usual
21 Dec 2021No filing that day or the nextup 9.19%+8.1 pts vs Nifty 5003.4× its usual move · volume 1.0× usual

Last results date

Gennex Laboratories annual reports, presentations and earnings calls

Annual reports24

Gennex Laboratories share news and announcements

Oct 2026

Sep 2026

Aug 2026

Jul 2026

Jun 2026

May 2026

Apr 2026

Feb 2026

Nov 2025

Oct 2025

Sep 2025

Aug 2025

Jul 2025

How the price met the news

Sharp moves